|
VBI researchers develop new method for breast cancer biomarker discovery (EurekAlert!)
( Virginia Tech ) Three researchers from the Virginia Bioinformatics Institute (VBI) at Virginia Tech have developed and evaluated a new one-step bioanalytical approach that allows them to profile in detail complex cellular extracts of proteins. The method has allowed the scientists to look at how the levels of proteins change in breast cancer cells when they are treated with hormones or cancer ...
(Jun 9, 2009)
23andMe Partners with Personalized Rx Platform Developer on Parkinson's Project (GenomeWeb News)
BOSTON – Consumer genomics firm 23andMe has partnered with PatientsLikeMe, a company that facilitates the sharing of patient outcomes data, to conduct research on Parkinson's disease.
(Jun 9, 2009)
Researchers develop new method for breast cancer biomarker discovery (PhysOrg)
Three researchers from the Virginia Bioinformatics Institute (VBI) at Virginia Tech have developed and evaluated a new one-step bioanalytical approach that allows them to profile in detail complex cellular extracts of proteins. The method has allowed the scientists to look at how the levels of proteins change in breast cancer cells when they are treated with hormones or cancer drugs like ...
(Jun 9, 2009)
Blog - Genetic Tests on the Horizon (Technology Review)
The latest in genetic testing from the Consumer Genomics Conference.
(Jun 9, 2009)
Research and Markets: Riding the Biotech Economic Tsunami - Surfing to Safety or Wipeout? (Business Wire via Yahoo! Finance)
DUBLIN----Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Riding the Biotech Economic Tsunami - Surfing to Safety or Wipeout?" to their offering.
(Jun 10, 2009)
Sensitive And Specific Kits For Proteoglycan Research (BioresearchOnline)
amsbio, specialists in high purity reagents for glycobiology and glycoanalysis, has announced a number of new and unique kits for proteoglycan research.
(Jun 10, 2009)
Inventors get advice on selling creations (The Buffalo News)
The Ph. D. s were the students Tuesday at the University at Buffalo's downtown campus.
(Jun 10, 2009)
Stellar Pharmaceuticals Inc. Announces Watson Pharma, Inc. Has Received a Conditional IDE Approval for Stellar's ... (Marketwire)
LONDON, ONTARIO--(Marketwire - June 10, 2009) - Stellar Pharmaceuticals Inc. ("Stellar" or the "Company") (OTCBB:SLXCF) is pleased to announce that its United States licensee, Watson Pharma, Inc. ("Watson") (NYSE:WPI), has received a conditional approval of their Investigational Device Exemption (IDE) to conduct clinical work with Uracyst(R) from The Food and Drug Administration (FDA) in the ...
(Jun 10, 2009)
Roche NimbleGen Introduces The MS 200 Microarray Scanner, Unleashing The Full Potential Of NimbleGen Arrays (DataCollectionOnline)
Roche NimbleGen introduces a new high-resolution scanning instrument, the NimbleGen MS 200 Microarray Scanner. The MS 200 is the first scanner optimized to reveal the full potential and capture the complete picture from all NimbleGen DNA microarrays
(Jun 10, 2009)
New Method For Breast Cancer Biomarker Discovery (Science Daily)
Bioinformatics researchers have developed and evaluated a new one-step bioanalytical approach that allows them to profile in detail complex cellular extracts of proteins. The method has allowed the scientists to look at how the levels of proteins change in breast cancer cells when they are treated with hormones or cancer drugs like tamoxifen.
(Jun 10, 2009)
Mitrionics Announces New Version of Software Development Kit for Next Generation High Performance Computing (Marketwire)
Mitrion Version 2.0 Boosts Parallel Programming Productivity and Enables High Performance Application Development Systems
(Jun 10, 2009)
OA publisher accepts fake paper (The Scientist)
Are author fees spawning dodgy open access publishers?
(Jun 10, 2009)
New Method For Breast Cancer Biomarker Discovery Developed By VBI Researchers (Medical News Today)
Three researchers from the Virginia Bioinformatics Institute (VBI) at Virginia Tech have developed and evaluated a new one-step bioanalytical approach that allows them to profile in detail complex cellular extracts of proteins.
(Jun 10, 2009)
Well, If You Don't Want It... (GenomeWeb News)
Kathleen Sebelius, the Secretary of Health and Human Services, went down to Capitol Hill where Senators Tom Harkin and Arlen Specter gave her a hard time about the small, $442 million increase that HHS has projected for the 2010 National Institutes of Health budget, reports The Scientist . "I would urge you to take another look at that figure," Specter says.
(Jun 10, 2009)
Read, But Don't Tell (GenomeWeb News)
A team of physicists made an exciting finding at the same time as a team of competitors, wrote it up, submitted it to Nature , and then submitted the preprint to arXiv -- an archive that many astronomers and physicists race to submit to.
(Jun 10, 2009)
This Week in Genome Research (GenomeWeb News)
This week in Genome Research , scientists at the University Hospital Regensburg in Germany have used a "novel approach that is based on the separation of a genome into methylated and unmethylated fractions" to scan for differential DNA methylation in human conventional CD4+ T cells and CD4+CD25+ regulatory T cells.
(Jun 10, 2009)
Quebec Drug-Discovery Consortium Awards $7.2M to Four Public-Private Research Teams (GenomeWeb News)
The Quebec Consortium for Drug Discovery , a public-private partnership launched last year to commercialize early-stage drug-discovery tools of interest to Canadian pharmaceutical companies, announced yesterday the winners of its inaugural grant competition.
(Jun 10, 2009)
University of Copenhagen Opens Novo Nordisk Foundation Center for Protein Research (GenomeWeb News)
The University of Copenhagen has officially opened the Novo Nordisk Foundation Center for Protein Research, which was created from the largest donation ever awarded to a Danish university for basic scientific research.
(Jun 10, 2009)
Due Diligence and Deception (GenomeWeb News)
A post by Vivian Cheng at Science Progress chronicles a recent accusation of data-falsification in a study on a bone-growth treatment. Timothy Kuklo, a former Army orthopedic surgeon now at Washington University in St. Louis authored an article in the British Journal of Bone and Joint Surgery that said Medtronic's Infuse was better at treating severe leg injuries suffered by soldiers than ...
(Jun 10, 2009)
EMBOSS Project Lands $1.2M BBSRC Grant, Plans Software Suite Expansion (GenomeWeb News)
The European Molecular Biology Open Software Suite has received a £750,000 ($1.2 million) grant from the UK's funding agency Biotechnology and Biological Sciences Research Council that will support the project through the end of 2011, according to its developers.
(Jun 10, 2009)
RainDance Technologies Announces Shipment of RDT 1000, Sequence Enrichment Solution to TGen Researchers (Business Wire via Yahoo! Finance)
LEXINGTON, Mass.----RainDance Technologies, Inc., today announced the shipment of an RDT 1000 and Sequence Enrichment Solution to the Translational Genomics Research Institute .
(Jun 10, 2009)
Caprion Proteomics Researcher and Colleagues Land $1.8M Grant to ID New Type-2 Diabetes Biomarkers (GenomeWeb News)
A team of scientists headed by a Caprion Proteomics researcher was awarded a three-year, C$2 million ($1.8 million) grant to use the firm's CellCarta technology to discover new biomarkers that can accurately measure pancreatic beta-cell mass and function and to determine the most effective treatment for type-2 diabetes.
(Jun 10, 2009)
Neighbors in the news (This Week German Village)
Dr. Joan Pryor-McCann, a professor of nursing at Otterbein College and a resident of German Village, was recently selected from a competitive pool to participate in the National Human Genome Research Institute's 2009 Summer Workshop in Genomics.
(Jun 10, 2009)
Researchers Identify Four New Targets for Breast Cancer (Newswise)
Four suspects often found at the scene of the crime in cancer are guilty of the initiation and progression of breast cancer in mice that are resistant to the disease, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the June edition of Cancer Cell.
(Jun 10, 2009)
Mitrionics Announces New Version of Software Development Kit for Next Generation High Performance Computing (Marketwire)
Mitrion Version 2.0 Boosts Parallel Programming Productivity and Enables High Performance Application Development Systems
(Jun 10, 2009)
OncoTyrol to Conduct Validation Studies on Protagen UniArray Technology (GenomeWeb News)
NEW YORK (GenomeWeb News) – Protagen said today that it has formed a collaboration with OncoTyrol to conduct validation studies on the firm's UniArray technology platform.
(Jun 10, 2009)
Gentronix, Apredica to Collaborate on Predictive Toxicology (GenomeWeb News)
NEW YORK (GenomeWeb News) – Gentronix and Apredica said today that they will collaborate on providing drug-discovery support services with a focus on predictive toxicology.
(Jun 10, 2009)
Life After GWAS: For Some Researchers, Focus Shifts to Rare Variants, CNVs (GenomeWeb News)
SAN FRANCISCO – Over the last several years, genome-wide association studies have become the primary method for identifying variations associated with human disease, but the approach has shortcomings that are leading some in the genomics community to push more aggressively into the post-GWAS era.
(Jun 10, 2009)
DNAVision, BioXpr Integrate Genetic Analysis, Informatics (GenomeWeb News)
NEW YORK (GenomeWeb News) – DNAVision said today that it has teamed with BioXpr to offer an integrated genetic analysis and bioinformatics platform.
(Jun 10, 2009)
Illumina Partners with DTC Genomics Firms to Offer Whole Genome Sequencing for $48K (GenomeWeb News)
BOSTON — Illumina and four direct-to-consumer genomics firms — 23andMe, Knome, Navigenics, and Decode Genetics — have joined forces to bring whole genome sequencing analysis of genetic risk information to customers.
(Jun 10, 2009)
Identifying the potential for tamoxifen resistance in patients (EurekAlert!)
( American Society for Biochemistry and Molecular Biology ) Tamoxifen is a widely used and highly successful drug in the treatment of breast cancer, though resistance to tamoxifen is still a concern in recurrent disease, since therapy resistant metastatic tumor cells are a major cause of death. Now, researchers have uncovered a protein profile that may accurately predict whether a cancer will be ...
(Jun 10, 2009)
Knome and SeqWright to Offer Personal Genomics Services Through CLIA-Certified Laboratory (Business Wire via Yahoo! Finance)
CAMBRIDGE, Mass.----Knome, a recognized pioneer in the personal genomics field, today announced that it will collaborate with SeqWright, a world-leader in custom genomic and molecular biology services, to offer its personal genome sequencing and analysis services through a CLIA-certified laboratory.
(Jun 10, 2009)
Found: 1 in 3 billion (EurekAlert!)
( University of British Columbia ) Vancouver scientists from the Ovarian Cancer Research (OvCaRe) Program at BC Cancer Agency and Vancouver Coastal Health Research Institute have discovered that there appears to be a single spelling mistake in the genetic code of granulosa cell tumors, a rare and often untreatable form of ovarian cancer. The discovery marks the beginning of a new era of cancer ...
(Jun 10, 2009)
Finding The Potential For Tamoxifen Resistance In Patients (redOrbit)
Tamoxifen is a widely used and highly successful drug in the treatment of breast cancer, though resistance to tamoxifen is still a concern in recurrent disease (affecting 25-35% of patients), since therapy resistant metastatic tumor cells are a major cause of death.
(Jun 10, 2009)
J. Craig Venter sees change from genomics (San Francisco Chronicle)
He is one of the leading scientists of the 21st century, a man who has rattled the establishment, turned biology into a high-stakes race and was the first human being to have his entire genome sequenced. J. Craig Venter grew up in Millbrae and was considering...
(Jun 10, 2009)
J. Craig Venter addresses UCSD grads (La Jolla Light)
J. Craig Venter Photo by: Courtesy Genomics leader part of ceremony BY KIRSTEN ADAMS Intern Genomics pioneer J. Craig Venter urged a class of 56 graduates to trust their instincts, in a speech on Saturday at the University of California San Diego Skaggs School of Pharmaceutical Sciences commencement. Venter is most notable for his work with the National Institute of Health, his development of ...
(Jun 11, 2009)
Found: 1 in 3 billion (PhysOrg)
Vancouver scientists from the Ovarian Cancer Research (OvCaRe) Program at BC Cancer Agency and Vancouver Coastal Health Research Institute have discovered that there appears to be a single spelling mistake in the genetic code of granulosa cell tumours, a rare and often untreatable form of ovarian cancer.
(Jun 11, 2009)
J. Craig Venter sees change from genomics (San Francisco Chronicle)
He is one of the leading scientists of the 21st century, a man who has rattled the establishment, turned biology into a high-stakes race and was the first human being to have his entire genome sequenced. J. Craig Venter grew up in Millbrae and was considering...
(Jun 11, 2009)
Biosystems International Establishes Licensing Agreement with Lohocla Research Institute to Search for Novel ... (Business Wire via Yahoo! Finance)
PARIS----Biosystems International a biotechnology company focused on the development of novel monoclonal antibody-based diagnostics for cancer and metabolic diseases has established a licensing agreement with the Lohocla Research Corporation for the use of BSI's patented monoclonal antibody proteomics platform for the discovery of novel alcoholism liver disease biomarkers in blood.
(Jun 11, 2009)
MCST mulls partnership with biology laboratory (di-ve)
The Malta Council for Science and Technology is considering collaborating with the world-renowned European Molecular Biology Laboratory. “Scientific international organisations like EMBL are the world centres of advanced technology in various fields.
(Jun 11, 2009)
454 Life Sciences Celebrates a Revolution in Genomics - Announces the 454th Peer-Reviewed Publication Using the Genome ... (Business Wire via Yahoo! Finance)
BRANFORD, Conn.----In September 2005, a paper published in the journal Nature introducing a novel, highly parallel sequencing system capable of producing 100-fold greater throughput than the state-of-the-art capillary electrophoresis instrument.
(Jun 11, 2009)
MDRNA, Inc. Granted Request to Remain Listed on The NASDAQ Global Market (Marketwire via Yahoo! Finance)
MDRNA, Inc. announced today that on Wednesday, June 10, 2009, the NASDAQ Hearings Panel granted the request of the Company to remain listed on The NASDAQ Global Market and that the Company had until August 31, 2009 to establish a minimum $10.0 million in stockholders' equity or demonstrate compliance with one of the alternative listing criteria per NASDAQ Marketplace Rule 5450(b).
(Jun 11, 2009)
MDRNA, Inc. Granted Request to Remain Listed on The NASDAQ Global Market (Marketwire)
BOTHELL, WA--(Marketwire - June 11, 2009) - MDRNA, Inc. ( NASDAQ : MRNA ) announced today that on Wednesday, June 10, 2009, the NASDAQ Hearings Panel granted the request of the Company to remain listed on The NASDAQ Global Market and that the Company had until August 31, 2009 to establish a minimum $10.0 million in stockholders' equity or demonstrate compliance with one of the alternative ...
(Jun 11, 2009)
Gentel Biosciences Announces Invitation to Collaborate in Clinical Research and Development Consortium for Diseases of ... (Business Wire via Yahoo! Finance)
MADISON, Wis.----Gentel Biosciences, an acknowledged leader in protein microarray technology, announced it has been invited to join a collaborative Clinical Research and Development consortium using novel technologies developed by the company to gain insight into major diseases of pregnancy.
(Jun 11, 2009)
Four New Targets For Breast Cancer Identified By Researchers (Medical News Today)
Four suspects often found at the scene of the crime in cancer are guilty of the initiation and progression of breast cancer in mice that are resistant to the disease, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the June edition of Cancer Cell.
(Jun 11, 2009)
Spelling Mistake In The Genetic Code That Causes A Type Of Ovarian Cancer (redOrbit)
Eureka! Vancouver scientists from the Ovarian Cancer Research (OvCaRe) Program at BC Cancer Agency and Vancouver Coastal Health Research Institute have discovered that there appears to be a single spelling mistake in the genetic code of granulosa cell tumours, a rare and often untreatable form of ovarian cancer.
(Jun 11, 2009)
Persistent Systems Enables Christiana Care Health System to Adopt caTissue Application (Marketwire)
Seamless Migration of Legacy Data to caTissue Accelerates Clinical Research
(Jun 11, 2009)
Knome, SeqWright to Provide Personal Genomics Services through CLIA Lab (GenomeWeb News)
NEW YORK (GenomeWeb News) – Personal genomics company Knome announced that it plans to collaborate with custom genomic and molecular biology services provider SeqWright to offer its personal genome sequencing and analysis service through SeqWright's CLIA-certified laboratory.
(Jun 11, 2009)
MCST considering collaboration with EMBL (Malta Star)
As part of its new strategy for Science, Technology, Research and Innovation in Malta, the Malta Council for Science and Technology (MCST) is considering collaborating with the European Molecular Biology Laboratory (EMBL) - a Scientific International Organisation of world wide repute.
(Jun 11, 2009)
Getting into the Game (GenomeWeb News)
As our sister publications Pharmacogenomics Reporter and In Sequence report, Illumina has gotten into the personal genome-sequencing game. For $48,000 Illumina will sequence someone's genome, using its Genome Analyzer II, and provided that person has a prescription.
(Jun 11, 2009)
|
